首页> 外文期刊>Stem Cells >Concise Review: Engineering Myocardial Tissue: The Convergence of Stem Cells Biology and Tissue Engineering Technology
【24h】

Concise Review: Engineering Myocardial Tissue: The Convergence of Stem Cells Biology and Tissue Engineering Technology

机译:简要评论:心肌工程组织:干细胞生物学与组织工程技术的融合

获取原文
获取原文并翻译 | 示例
       

摘要

Advanced heart failure represents a leading public health problem in the developed world. The clinical syndrome results from the loss of viable and/or fully functional myocardial tissue. Designing new approaches to augment the number of functioning human cardiac muscle cells in the failing heart serve as the foundation of modern regenerative cardiovascular medicine. A number of clinical trials have been performed in an attempt to increase the number of functional myocardial cells by the transplantation of a diverse group of stem or progenitor cells. Although there are some encouraging suggestions of a small early therapeutic benefit, to date, no evidence for robust cell or tissue engraftment has been shown, emphasizing the need for new approaches. Clinically meaningful cardiac regeneration requires the identification of the optimum cardio-genic cell types and their assembly into mature myocardial tissue that is functionally and electrically coupled to the native myocardium. We here review recent advances in stem cell biology and tissue engineering and describe how the convergence of these two fields may yield novel approaches for cardiac regeneration.
机译:晚期心力衰竭是发达国家的主要公共卫生问题。临床综合征是由于存活的和/或功能完整的心肌组织丧失所致。设计新方法以增加衰竭心脏中功能性人类心肌细胞的数量,是现代再生心血管医学的基础。为了通过移植多种干细胞或祖细胞来增加功能性心肌细胞的数量,已经进行了许多临床试验。尽管有一些令人鼓舞的建议,即早期的治疗益处很小,但是迄今为止,还没有证据表明细胞或组织能够牢固植入,从而强调了对新方法的需求。具有临床意义的心脏再生需要确定最佳的心源性细胞类型,并将其组装成功能上和电上与天然心肌相连的成熟心肌组织。我们在这里回顾了干细胞生物学和组织工程学的最新进展,并描述了这两个领域的融合如何可能产生心脏再生的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号